TWIST BIOSCIENCE CORP (TWST)
US90184D1000 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to TWST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.93. This target is 27.86% above the current price.
TWST was analyzed by 16 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TWST.
In the previous month the buy percentage consensus was at a similar level.
TWST was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-05 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-01-25 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-18 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-17 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-09-27 | Berenberg | Initiate | Buy |
| 2023-08-07 | Barclays | Maintains | Overweight -> Overweight |
| 2023-07-13 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-05-08 | Barclays | Maintains | Overweight |
| 2023-05-08 | Baird | Maintains | Outperform |
| 2023-04-19 | Goldman Sachs | Maintains | Neutral |
| 2023-04-18 | Goldman Sachs | Maintains | Neutral |
| 2023-02-06 | Barclays | Maintains | Overweight |
| 2023-02-06 | Baird | Maintains | Outperform |
| 2023-02-06 | Goldman Sachs | Maintains | Neutral |
| 2023-01-30 | Barclays | Maintains | Overweight |
| 2023-01-05 | ScotiaBank | Initiate | Sector Outperform |
| 2023-01-03 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2022-11-21 | SVB Leerink | Maintains | Market Perform |
| 2022-11-21 | Barclays | Maintains | Overweight |
| 2022-11-21 | Baird | Maintains | Outperform |
| 2022-10-07 | SVB Leerink | Maintains | Market Perform |
| 2022-10-06 | Barclays | Maintains | Overweight |
| 2022-08-08 | SVB Leerink | Maintains | Market Perform |
| 2022-08-08 | Barclays | Maintains | Overweight |
| 2022-07-13 | Barclays | Maintains | Overweight |
| 2022-05-09 | Barclays | Maintains | Overweight |
| 2022-04-13 | Goldman Sachs | Maintains | Neutral |
| 2022-02-07 | SVB Leerink | Maintains | Market Perform |
| 2022-02-07 | Barclays | Maintains | Overweight |